These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 32779484)
1. Anti-migration and anti-invasion effects of 2-hydroxy-6-tridecylbenzoic acid is associated with the enhancement of CYP1B1 expression through activating the AMPK signaling pathway in triple-negative breast cancer cells. Zhou D; Zhao X; Yu M; Xu Y; Fu C; Zheng K; Xia C; Huang B; Ma S Nat Prod Res; 2021 Dec; 35(24):5924-5928. PubMed ID: 32779484 [TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect of 2-Hydroxy-6-tridecylbenzoic acid from ginkgo biloba sarcotestas through the aryl hydrocarbon receptor pathway in triple-negative breast cancer cells. Zhou D; Jiang C; Fu C; Chang P; Yang B; Wu J; Zhao X; Ma S Nat Prod Res; 2020 Mar; 34(6):893-897. PubMed ID: 30445863 [TBL] [Abstract][Full Text] [Related]
3. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway. Yang X; Yang R; Zhang Y; Shi Y; Ma M; Li F; Xie Y; Han X; Liu S Biomed Pharmacother; 2023 Sep; 165():115164. PubMed ID: 37478577 [TBL] [Abstract][Full Text] [Related]
4. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation. Pai JT; Chen XH; Leu YL; Weng MS Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593 [TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling. Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331 [TBL] [Abstract][Full Text] [Related]
6. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
7. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway. Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381 [TBL] [Abstract][Full Text] [Related]
8. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208 [TBL] [Abstract][Full Text] [Related]
9. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers. Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375 [TBL] [Abstract][Full Text] [Related]
10. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945 [TBL] [Abstract][Full Text] [Related]
11. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway. Wei C; Zou H; Xiao T; Liu X; Wang Q; Cheng J; Fu S; Peng J; Xie X; Fu J J Cell Mol Med; 2021 Nov; 25(21):10101-10110. PubMed ID: 34609056 [TBL] [Abstract][Full Text] [Related]
12. Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer. Ozman Z; Ozbek Iptec B; Sahin E; Guney Eskiler G; Deveci Ozkan A; Kaleli S Mol Biol Rep; 2021 Feb; 48(2):1335-1343. PubMed ID: 33515347 [TBL] [Abstract][Full Text] [Related]
13. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. Shieh JM; Chen YC; Lin YC; Lin JN; Chen WC; Chen YY; Ho CT; Way TD J Agric Food Chem; 2013 Jul; 61(26):6366-75. PubMed ID: 23777448 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of the Zhao XD; Dong N; Man HT; Fu ZL; Zhang MH; Kou S; Ma SL Biomed Rep; 2013 Sep; 1(5):797-801. PubMed ID: 24649031 [No Abstract] [Full Text] [Related]
16. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation. Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947 [TBL] [Abstract][Full Text] [Related]
17. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related]
18. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-κB and Wnt/β-catenin signaling pathway. Hseu YC; Lin YC; Rajendran P; Thigarajan V; Mathew DC; Lin KY; Way TD; Liao JW; Yang HL Food Chem Toxicol; 2019 Feb; 124():219-230. PubMed ID: 30529123 [TBL] [Abstract][Full Text] [Related]
19. Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator. Lee KH; Hsu EC; Guh JH; Yang HC; Wang D; Kulp SK; Shapiro CL; Chen CS J Biol Chem; 2011 Nov; 286(45):39247-58. PubMed ID: 21917926 [TBL] [Abstract][Full Text] [Related]
20. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3. Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]